| Drug Name |
Acitretin |
| Drug ID |
BADD_D00036 |
| Description |
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. |
| Indications and Usage |
For the treatment of severe psoriasis in adults. |
| Marketing Status |
approved |
| ATC Code |
D05BB02 |
| DrugBank ID |
DB00459
|
| KEGG ID |
D02754
|
| MeSH ID |
D017255
|
| PubChem ID |
5284513
|
| TTD Drug ID |
D05QDC
|
| NDC Product Code |
17337-0003; 59981-011; 0093-1136; 0115-1752; 42291-087; 62147-0145; 0115-1751; 42794-081; 0378-7020; 71214-0698; 42291-088; 58159-058; 71052-692; 0115-1753; 17337-0004; 71214-0667; 0115-1750; 71214-0668; 71214-0669; 42291-086; 42794-080; 0093-1135; 0093-1138; 62147-0146; 76055-0001; 42794-083; 0378-7023 |
| UNII |
LCH760E9T7
|
| Synonyms |
Acitretin | Etretin | Isoacitretin | Isoetretin | Ro 10-1670 | Ro 101670 | Ro-10-1670 | Ro101670 | 13-cis-Acitretin | Neotigason | Soriatane | Acitretin, (Z,E,E,E)-Isomer | Ro-13-7652 | Ro137652 | Ro 13-7652 | Ro 137652 |
